Stream A: Fully Subsidised – Restricted Groups
Although all individuals living with type 1 diabetes in Australia can now access subsidised CGM technologies, some people are eligible to access fully subsidised CGM products – they are outlined below:
Stream B: Partially Subsidised – All others living with type 1 diabetes
As of 1 July 2022, the government expanded access to subsidised CGM technologies for all other individuals living with type 1 diabetes. The individuals in this stream can access partially subsidised CGM technologies for a small co-payment Via this stream, the cost of Dexcom G6 is $32.10/month.
To check if your patient may fit one of the above groups and so can access fully subsidised CGM, please click on the relevant title – this will redirect you to the eligibility criteria on the NDSS website.